Catherine Norton

Dr. Catherine Norton

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Ioannis ZabetakisIoannis Zabetakis
Ioannis Zabetakis
Ronan LordanRonan Lordan
Ronan Lordan
CNCatherine Norton
Catherine Norton
Alexandros TsouprasAlexandros Tsoupras
Alexandros Tsoupras
The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has engulfed the world, affecting more than 180 countries. As a result, there has been considerable economic distress globally and a significant loss of life. Sadly, the vulnerable and immunocompromised in our societies seem to be more susceptible to severe COVID-19 complications. Global public health bodies and governments have ignited strategies and issued advisories on various handwashing and hygiene guidelines, social distancing strategies, and, in the most extreme cases, some countries have adopted “stay in place” or lockdown protocols to prevent COVID-19 spread. Notably, there are several significant risk factors for severe COVID-19 infection. These include the presence of poor nutritional status and pre-existing noncommunicable diseases (NCDs) such as diabetes mellitus, chronic lung diseases, cardiovascular diseases (CVD), obesity, and various other diseases that render the patient immunocompromised. These diseases are characterized by systemic inflammation, which may be a common feature of these NCDs, affecting patient outcomes against COVID-19. In this review, we discuss some of the anti-inflammatory therapies that are currently under investigation intended to dampen the cytokine storm of severe COVID-19 infections. Furthermore, nutritional status and the role of diet and lifestyle is considered, as it is known to affect patient outcomes in other severe infections and may play a role in COVID-19 infection. This review speculates the importance of nutrition as a mitigation strategy to support immune function amid the COVID-19 pandemic, identifying food groups and key nutrients of importance that may affect the outcomes of respiratory infections.

1 January 2016 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
CNCatherine Norton
Catherine Norton
Clodagh ToomeyClodagh Toomey
Clodagh Toomey
WMWilliam G McCormack
William G McCormack
PFPeter Francis
Peter Francis
JSJean Saunders
Jean Saunders
Phil JakemanPhil Jakeman
Phil Jakeman
Background: Key areas of research on the preservation of lean tissue mass (LTM) during aging are determinations of the protein requirement and optimal

1 January 2015 in Topics in Clinical Nutrition
Verified
Journal Article
Closed access
Clodagh ToomeyClodagh Toomey
Clodagh Toomey
ACAlexandra Cremona
Alexandra Cremona
KHKatie Hughes
Katie Hughes
CNCatherine Norton
Catherine Norton
Phil JakemanPhil Jakeman
Phil Jakeman

22 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Pablo Jorge Marcos-PardoPablo Jorge Marcos-Pardo
Pablo Jorge Marcos-Pardo
Noelia Gonzalez-GalvezNoelia Gonzalez-Galvez
Noelia Gonzalez-Galvez
AVAbraham López Vivancos
Abraham López Vivancos
Alejandro Espeso-GarcíaAlejandro Espeso-García
Alejandro Espeso-García
Luis Manuel Martínez-ArandaLuis Manuel Martínez-Aranda
Luis Manuel Martínez-Aranda
Raquel Vaquero-CristobalRaquel Vaquero-Cristobal
Raquel Vaquero-Cristobal
The revised European consensus defined sarcopenia as a progressive and generalized skeletal muscle disorder that is associated with an increased likelihood of adverse outcomes including falls, fractures, physical disability and mortality. The aim of this study was to determine the prevalence of sarcopenia and analyse the influence of diet, physical activity (PA) and obesity index as risk factors of each criteria of sarcopenia. A total of 629 European middle-aged and older adults were enrolled in this cross-sectional study. Anthropometrics were assessed. Self-reported PA and adherence to the Mediterranean diet were evaluated with the Global Physical Activity Questionnaire (GPAQ) and Prevention with Mediterranean Diet questionnaire (PREDIMED), respectively. The functional assessment included handgrip strength, lower body muscle strength, gait speed and agility/dynamic balance. Of the participants, 4.84% to 7.33% showed probable sarcopenia. Sarcopenia was confirmed in 1.16% to 2.93% of participants. Severe sarcopenia was shown by 0.86% to 1.49% of participants. Male; age group ≤65 years; lower body mass index (BMI); high levels of vigorous PA; and the consumption of more than one portion per day of red meat, hamburgers, sausages or cold cuts and/or preferential consumption of rabbit, chicken or turkey instead of beef, pork, hamburgers or sausages (OR = 0.126–0.454; all p < 0.013) resulted as protective factors, and more time of sedentary time (OR = 1.608–2.368; p = 0.032–0.041) resulted as a risk factor for some criteria of sarcopenia. In conclusion, age, diet, PA, and obesity can affect the risk of having low muscle strength, low muscle mass or low functional performance, factors connected with sarcopenia.

8 December 2016 in Biogerontology
Verified
Journal Article
Open access
PDF file
Peter FrancisPeter Francis
Peter Francis
WCWilliam Mc Cormack
William Mc Cormack
Clodagh ToomeyClodagh Toomey
Clodagh Toomey
CNCatherine Norton
Catherine Norton
JSJean Saunders
Jean Saunders
Phil JakemanPhil Jakeman
Phil Jakeman
The age-related decline in functional capability is preceded by a reduction in muscle quality. The purpose of this study was to assess the combined effects of progressive resistance training (PRT) and protein supplementation beyond habitual intakes on upper leg lean tissue mass (LTM), muscle quality and functional capability in healthy 50–70 years women. In a single-blinded, randomized, controlled design, 57 healthy older women (age 61.1 ± 5.1 years, 1.61 ± 0.65 m, 65.3 ± 15.3 kg) consumed 0.33 g/kg body mass of a milk-based protein matrix (PRO) for 12 weeks. Of the 57 women, 29 also engaged in a PRT intervention (PRO + PRT). In comparison to the PRO group (n = 28), those in the PRO + PRT group had an increase in upper leg LTM [0.04 (95% CI −0.07 to 0.01) kg vs. 0.13 (95% CI 0.08–0.18) kg, P = 0.027], as measured by Dual-energy X-ray absorptiometry; an increase in knee extensor (KE) torque [−1.6 (95% CI −7.3 to 4.4 N m) vs. 10.2 (95% CI 4.3–15.8 N m), P = 0.007], as measured from a maximal voluntary isometric contraction (Con-Trex MJ; CMV AG); and an increase in extended gait speed [-0.01 (95% CI −0.52–0.04) m s−1 vs. 0.10 (95% CI 0.05–0.22) m s−1, P = 0.001] as measured from a maximal 900 m effort. There was no difference between groups in the time taken to complete 5 chair rises or the number of chair rises performed in 30 s (P > 0.05). PRT in healthy older women ingesting a dietary protein supplement is an effective strategy to improve upper leg LTM, KE torque and extended gait speed in healthy older women.

21 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Robert W. DaviesRobert W. Davies
Robert W. Davies
JBJoseph Bass
Joseph Bass
BCBrian Carson
Brian Carson
CNCatherine Norton
Catherine Norton
MKMarta Kozior
Marta Kozior
Phil JakemanPhil Jakeman
Phil Jakeman
Background: The aim of this study was to investigate the effect of whey protein supplementation on myofibrillar protein synthesis (myoPS) and muscle recovery over a 7-d period of intensified resistance training (RT). Methods: In a double-blind randomised parallel group design, 16 resistance-trained men aged 18 to 35 years completed a 7-d RT protocol, consisting of three lower-body RT sessions on non-consecutive days. Participants consumed a controlled diet (146 kJ·kg−1·d−1, 1.7 g·kg−1·d−1 protein) with either a whey protein supplement or an isonitrogenous control (0.33 g·kg−1·d−1 protein). To measure myoPS, 400 ml of deuterium oxide (D2O) (70 atom %) was ingested the day prior to starting the study and m. vastus lateralis biopsies were taken before and after RT-intervention. Myofibrillar fractional synthetic rate (myoFSR) was calculated via deuterium labelling of myofibrillar-bound alanine, measured by gas chromatography-pyrolysis-isotope ratio mass spectrometry (GC-Pyr-IRMS). Muscle recovery parameters (i.e., countermovement jump height, isometric-squat force, muscle soreness and serum creatine kinase) were assessed daily. Results: MyoFSR PRE was 1.6 (0.2) %∙d−1 (mean (SD)). Whey protein supplementation had no effect on myoFSR (p = 0.771) or any recovery parameter (p = 0.390–0.989). Conclusions: Over an intense 7-d RT protocol, 0.33 g·kg−1·d−1 of supplemental whey protein does not enhance day-to-day measures of myoPS or postexercise recovery in resistance-trained men.